One-year initial efficacy and safety outcomes of the premounted dry-pericardium Vienna self-expandable transcatheter aortic valve system: A first-in-human VIVA feasibility study.
Kasparas BriedisEgle RumbinaiteAli AldujeliKamilija BriedeMartynas JurenasPovilas JakuskaAntanas JankauskasIndre CeponieneTadas LenkutisJurgita PlisieneRimantas BenetisRemigijus ZaliunasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
The study indicates the Vienna valve as a potential option for severe symptomatic aortic stenosis, designed to streamline the procedure and potentially lower healthcare costs by reducing resource and equipment needs, also procedural errors. Further research is essential to thoroughly evaluate its safety and efficacy.
Keyphrases
- aortic valve
- aortic stenosis
- transcatheter aortic valve replacement
- aortic valve replacement
- transcatheter aortic valve implantation
- healthcare
- ejection fraction
- left ventricular
- endothelial cells
- coronary artery disease
- induced pluripotent stem cells
- emergency department
- early onset
- type diabetes
- patient safety
- minimally invasive
- risk assessment
- drug induced
- adipose tissue
- human health
- adverse drug
- metabolic syndrome
- mitral valve
- health insurance
- social media